Agile Therapeutics (STU:0AL) Days Payable : 345.76 (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Agile Therapeutics Days Payable?

Agile Therapeutics's average Accounts Payable for the three months ended in Dec. 2023 was €7.61 Mil. Agile Therapeutics's Cost of Goods Sold for the three months ended in Dec. 2023 was €2.01 Mil. Hence, Agile Therapeutics's Days Payable for the three months ended in Dec. 2023 was 345.76.

The historical rank and industry rank for Agile Therapeutics's Days Payable or its related term are showing as below:

STU:0AL' s Days Payable Range Over the Past 10 Years
Min: 214.1 Med: 395.38 Max: 3679.77
Current: 330.94

During the past 12 years, Agile Therapeutics's highest Days Payable was 3679.77. The lowest was 214.10. And the median was 395.38.

STU:0AL's Days Payable is ranked better than
90.06% of 976 companies
in the Drug Manufacturers industry
Industry Median: 86.915 vs STU:0AL: 330.94

Agile Therapeutics's Days Payable declined from Dec. 2022 (358.45) to Dec. 2023 (345.76). It may suggest that Agile Therapeutics accelerated paying its suppliers.

Agile Therapeutics Days Payable Historical Data

The historical data trend for Agile Therapeutics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Agile Therapeutics Days Payable Chart

Agile Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

3,788.45

209.44

424.42

356.44

Agile Therapeutics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Payable	Get a 7-Day Free Trial															358.45	414.16	329.08	238.41	345.76

Competitive Comparison of Agile Therapeutics's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Agile Therapeutics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Agile Therapeutics's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Agile Therapeutics's Days Payable distribution charts can be found below:

* The bar in red indicates where Agile Therapeutics's Days Payable falls into.

Agile Therapeutics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Agile Therapeutics's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (7.301	+	8.779)	/	2 )	/	8.233	*	365
=	8.04					/	8.233	*	365
=	356.44

Agile Therapeutics's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (6.446	+	8.779)	/	2 )	/	2.009	*	365 / 4
=	7.6125					/	2.009	*	365 / 4
=	345.76

Agile Therapeutics Days Payable Related Terms

Thank you for viewing the detailed overview of Agile Therapeutics's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Agile Therapeutics (STU:0AL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Agile Therapeutics Inc (STU:0AL) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

AGRX:USA

Address

500 College Road East, Suite 310, Princeton, NJ, USA, 08540

Website

https://www.agiletherapeutics.com

Agile Therapeutics Inc is a women's healthcare company to fulfill the unmet health needs of women. Its product candidates are designed to provide women with contraceptive options. The firm's initial product, Twirla, (levonorgestrel and ethinyl estradiol) transdermal system is a non-daily prescription contraceptive. Twirla is based on proprietary transdermal patch technology, called Skinfusion, which is designed to allow drug delivery through the skin. The Company views its operations and manages its business in one operating and reporting segment, which is the business of commercializing its transdermal patch for use in contraception.

Agile Therapeutics (STU:0AL) Headlines

No Headlines